CCNP and cancer: CCNP upregulation increased the expression of several the drug efflux transporters tested (ABCC1 p-values: A549 = 0.0181; LoVo = 0.9358; MCF7 = 0.0247) (Fig. 3B and Supplementary Fig. S5B), supporting the notion that CCNP may contribute to the drug resistance of cancer cells.